Chevy Chase Trust Holdings, Inc. Novartis Ag Transaction History
Chevy Chase Trust Holdings, Inc.
- $33.7 Billion
- Q2 2025
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 1,135,326 shares of NVS stock, worth $133 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
1,135,326
Previous 1,101,372
3.08%
Holding current value
$133 Million
Previous $123 Million
11.9%
% of portfolio
0.41%
Previous 0.4%
Shares
32 transactions
Others Institutions Holding NVS
# of Institutions
1,545Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.39 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.22 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.01 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$827 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$793 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $252B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...